Navigation Links
FHI Selected as Preferred Provider to a Consortium of Product Development Partnerships
Date:3/30/2011

RESEARCH TRIANGLE PARK, N.C., March 30, 2011 /PRNewswire-USNewswire/ -- FHI has been selected as one of six preferred providers offering their clinical research expertise to a consortium of 14 global health Product Development Partnerships (PDPs). The consortium of PDPs is working to develop and deliver affordable treatments and vaccines that will help improve the lives of some of the world's most vulnerable people.

FHI's forty years of research experience has focused on a multitude of infectious and neglected diseases, such as HIV, HSV, HPV, other sexually transmitted diseases, malaria, and seasonal and pandemic influenza.  FHI has strong history delivering the highest quality research in resource constrained settings and has been recognized globally for its leadership in the ethical treatment of trial participants.  

"This consortium has the potential to find cures for the most widespread diseases, like tuberculosis, malaria, influenza, dengue fever, HIV and Chagas disease," said Albert J. Siemens, FHI Chairman and Chief Executive Officer.  "FHI is honored to be selected as a preferred provider, offering our expertise and experience to the critical work being undertaken by the PDPs."

The consortium members are funded, in part, by the Bill & Melinda Gates Foundation. This preferred provider agreement offers consortium members an opportunity to work with pre-qualified organizations, including FHI, thereby consolidating resources, and achieving heightened efficiencies while maintaining the highest standards.  The synergies and efficiencies of partnering with the preferred providers are expected to be significant.  

FHI partners with government, non-governmental, and private sector entities on major pharmaceutical and biotechnology clinical trials worldwide.

About FHI

FHI is a global health and development organization whose science-based programs bring lasting change to the world's most vulnerable people.  FHI's approach is rigorous and evidence-driven.  Among FHI's worldwide staff of 2,500 are leading physicians, scientists, and technical experts in health, development, and management.  FHI's work is global in scale yet country-focused, with international offices staffed by local professionals.  Since 1971, FHI has worked with 1,400 partners in 125 countries, forging strong relationships with governments, diverse organizations, the private sector and communities.  By applying science to healthcare programs and clinical research, FHI is helping countries make measurable progress against disease, poverty, and inequity – improving lives for millions.

Contact Info:
Matthew Matassa
202-341-6519
mmatassa@fhi.org


'/>"/>
SOURCE Family Health International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dynatronics Selected for Inclusion in RB Milestone Portfolio
2. Shanghai ChemPartner Announces Being Selected as Antibody Service Partner by Shenogen Pharma Group
3. NewCardio Study of QTinno Accuracy Selected for Presentation at the National Scientific Meeting of the American Society of Clinical Pharmacology and Therapeutics
4. BioSurplus Selected to Liquidate Discovery Laboratory Equipment
5. Cognizant Selected by Lilly to Deliver Commercial Operations Solutions to Enhance Sales and Marketing Effectiveness, Business Performance
6. Valence Health Selected by Cleveland Clinic to Support Clinical Integration Program
7. Compumedics Home Sleep Testing System Selected for Use in US National Institute of Health (NIH)-Sponsored Multi-Ethnic Study of Atherosclerosis (MESA) Sleep Study
8. Cylene Selected to Present CK2 Inhibitor Multiple Myeloma Data at American Society of Hematology Meeting
9. GENFIT Selected by Windhover for the 2011 Top Biopharma Projects To Watch
10. PolyOne GLS Selected as Healthcare Industry Marketing Specialist for Santoprene™ TPV Medical Grades
11. Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2016 Orthopedic Implants (Including Spinal Implants, ... to Gain a Significant Market Share Owing to a Large ... ... According to a new report by Persistence ... Packaging: Clamshell Product Type Segment Projected to Witness a Significantly ...
(Date:12/2/2016)... , Dec. 2, 2016   CytoSorbents Corporation ... commercializing its European Union approved CytoSorb ® cytokine ... surgery patients worldwide, announced that Dr. Phillip Chan ... 9th Annual LD Micro Main Event investor conference ... at the Luxe Sunset Boulevard Hotel in ...
(Date:12/2/2016)... On Thursday, the NASDAQ Composite ended the trading ... edged 0.36% higher, to finish at 19,191.93; and the S&P ... as six out of nine sectors ended the day in ... Services equities: Myriad Genetics Inc. (NASDAQ: MYGN ), ... Inc. (NASDAQ: INCR ), and La Quinta Holdings ...
Breaking Medicine Technology:
(Date:12/2/2016)... York, NY (PRWEB) , ... December 02, 2016 ... ... featuring an inspirational interview of two ostomy patients, standing as living proof that ... people suffer from digestive diseases and issues that spike around the holidays. This ...
(Date:12/2/2016)... ... December 02, 2016 , ... The PAINWeekEnd Regional Conference ... and Spa in Honolulu, offering local frontline clinicians the opportunity to extend their ... The demand for supplemental training related to pain management has surged dramatically in ...
(Date:12/2/2016)... , ... December 02, 2016 , ... "Pro3rd Accents Volume ... editors to create versatile lower third titles with just a few clicks of the ... Volume 2 includes 30 lower third animations. Choose from various styles with accented animations, ...
(Date:12/2/2016)... FL (PRWEB) , ... December 02, 2016 , ... ‘Tis ... are winners of $1,000 each from the National Family Partnership and the Drug Enforcement ... families who decorated their homes and the 10 winning schools who decorated their campuses ...
(Date:11/30/2016)... Beach Gardens, FL (PRWEB) , ... November 30, ... ... in eating disorder and mental health treatment has announced the opening of a ... provides specialized partial hospitalization and intensive outpatient treatment for adults and adolescents, both ...
Breaking Medicine News(10 mins):